Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

St. Petersburg, Fla.–based eMed–ID has introduced a wearable device that tracks people prone to wander, such as Alzheimer's patients and those with autism.

Related Articles

A Double-Blind, Randomized, Placebo-Controlled Study of Fixed-Dose Aripiprazole in Children and Adolescents With Autistic Disorder
Journal of the American Academy of Child and Adolescent Psychiatry, 10/06/09    Relevance Score: 69%

Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry
European Archives of Psychiatry and Clinical Neuroscience, 10/12/09    Relevance Score: 67%

Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders
Biological Psychiatry, 11/17/09    Relevance Score: 66%

Autism and Asperger’s syndrome
InnovAiT, 10/22/09    Relevance Score: 66%

Association of Autistic Spectrum Disorders With Dystrophinopathies
Pediatric Neurology, 10/14/09    Relevance Score: 66%

Today in Medical Devices/Products...keeping you current

Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09

Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09

Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN
Allos Therapeutics, 12/01/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address